These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15034580)

  • 21. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies.
    Seino S
    Annu Rev Physiol; 1999; 61():337-62. PubMed ID: 10099692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Cartier EA; Conti LR; Vandenberg CA; Shyng SL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation in nucleotide-binding domains of sulfonylurea receptor 2 evokes Na-ATP-dependent activation of ATP-sensitive K+ channels: implication for dimerization of nucleotide-binding domains to induce channel opening.
    Yamada M; Ishii M; Hibino H; Kurachi Y
    Mol Pharmacol; 2004 Oct; 66(4):807-16. PubMed ID: 15258252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes.
    Rainbow RD; Lodwick D; Hudman D; Davies NW; Norman RI; Standen NB
    J Physiol; 2004 Jun; 557(Pt 3):785-94. PubMed ID: 15020694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM).
    Masia R; De Leon DD; MacMullen C; McKnight H; Stanley CA; Nichols CG
    Diabetes; 2007 May; 56(5):1357-62. PubMed ID: 17317760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of the KATP channel. Where's the clone?
    Nichols CG
    Cardiovasc Res; 1994 Jun; 28(6):727-8. PubMed ID: 7923270
    [No Abstract]   [Full Text] [Related]  

  • 28. Dominant missense mutations in ABCC9 cause Cantú syndrome.
    Harakalova M; van Harssel JJ; Terhal PA; van Lieshout S; Duran K; Renkens I; Amor DJ; Wilson LC; Kirk EP; Turner CL; Shears D; Garcia-Minaur S; Lees MM; Ross A; Venselaar H; Vriend G; Takanari H; Rook MB; van der Heyden MA; Asselbergs FW; Breur HM; Swinkels ME; Scurr IJ; Smithson SF; Knoers NV; van der Smagt JJ; Nijman IJ; Kloosterman WP; van Haelst MM; van Haaften G; Cuppen E
    Nat Genet; 2012 May; 44(7):793-6. PubMed ID: 22610116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
    Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.
    Wada Y; Yamashita T; Imai K; Miura R; Takao K; Nishi M; Takeshima H; Asano T; Morishita R; Nishizawa K; Kokubun S; Nukada T
    EMBO J; 2000 Sep; 19(18):4915-25. PubMed ID: 10990455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative subunits of the rat mesangial KATP: a type 2B sulfonylurea receptor and an inwardly rectifying K+ channel.
    Szamosfalvi B; Cortes P; Alviani R; Asano K; Riser BL; Zasuwa G; Yee J
    Kidney Int; 2002 May; 61(5):1739-49. PubMed ID: 11967023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
    Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
    Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
    Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The N-terminus of KIR6.2 limits spontaneous bursting and modulates the ATP-inhibition of KATP channels.
    Babenko AP; Gonzalez G; Bryan J
    Biochem Biophys Res Commun; 1999 Feb; 255(2):231-8. PubMed ID: 10049691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
    Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
    Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.
    Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK
    Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
    Stephan D; Stauss E; Lange U; Felsch H; Löffler-Walz C; Hambrock A; Russ U; Quast U
    Br J Pharmacol; 2005 Apr; 144(8):1078-88. PubMed ID: 15711591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.